Recent Finacing
Recent Raise
Nabriva Therapeutics is a Vienna- and Philadelphia-based biotech developing systemic pleuromutilin antibiotics, including lead candidate lefamulin for CABP and preclinical extended-spectrum pleuromutilins targeting resistant pathogens.
